GlassScriptPhysician profile
Steven C Butler
NPI 1174514228
$1,265.40
in general payments reported to CMS, 2019-2025
18 companies · $3.52 in 2025
The $3.52 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $144 · 2021: $124 · 2022: $65.49 · 2023: $244 · 2024: $325 · 2025: $3.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Education: $54.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.31 |
| Education | $54.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $246.73 | 2019-2024 | Vafseo, Auryxia |
| Astrazeneca Pharmaceuticals LP | $201.10 | 2019-2024 | Farxiga |
| Amgen INC. | $179.52 | 2019-2024 | Tavneos |
| Mallinckrodt Hospital Products INC. | $92.99 | 2021 | |
| Travere Therapeutics, INC. | $92.69 | 2023-2025 | Filspari |
| Bard Peripheral Vascular, INC. | $85.74 | 2019 | |
| Alexion Pharmaceuticals, INC. | $63.29 | 2023-2024 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $49.64 | 2019-2024 | Jynarque |
| Horizon Therapeutics Plc | $46.18 | 2023 | Krystexxa |
| Fresenius USA Marketing, INC. | $33.73 | 2022-2023 | Velphoro |
| Novartis Pharmaceuticals Corporation | $31.46 | 2023-2024 | |
| Vifor Pharma, INC. | $28.83 | 2023 | Veltassa, Korsuva |
| Daiichi Sankyo INC. | $25.65 | 2024 | Injectafer |
| Lilly USA, LLC | $20.89 | 2024 | Jardiance |
| Mallinckrodt Enterprises LLC | $19.12 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.08 | 2022 | |
| Aurinia Pharma U.S., INC. | $17.31 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.